Ocular Complications Following Vaccination for COVID-19: A One-Year Retrospective

• Published in: Vaccines (Basel) Vol. 10; no. 2; p. 342
• Main Authors: Haseeb, Abid A, Solyman, Omar, Abushanab, Mokhtar M, Abo Obaia, Ahmed S, Elhusseiny, Abdelrahman M
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 21.02.2022; MDPI
• Subjects: acute macular neuroretinopathy; Adverse events; Age; corneal graft rejection; coronavirus; Coronaviruses; COVID-19; COVID-19 vaccines; Diplopia; Drug dosages; Edema; Eyelid; Health care; Immunization; Influenza; Magnetic resonance imaging; Males; Medical research; Ophthalmology; Pandemics; Patients; Physicians; Primary care; Purpura; Retina; Review; SARS-CoV-2; Severe acute respiratory syndrome coronavirus 2; Statistical analysis; Thrombocytopenia; Thrombosis; Uveitis; Veins & arteries; Viral diseases; Beijing China; Austria; China; COVID-19; corneal graft rejection; SARS-CoV-2; acute macular neuroretinopathy; coronavirus; uveitis; vaccination
• ISSN: 2076-393X; 2076-393X
• DOI: 10.3390/vaccines10020342

Vaccination efforts as a mitigation strategy in the corona virus disease 2019 (COVID-19) pandemic are fully underway. A vital component of understanding the optimal clinical use of these vaccines is a thorough investigation of adverse events following vaccination. To date, some limited reports and reviews have discussed ocular adverse events following COVID-19 vaccination, but a systematic review detailing these reports with manifestations and clinical courses as well as proposed mechanisms has yet to be published. This comprehensive review one-year into vaccination efforts against COVID-19 is meant to furnish sound understanding for ophthalmologists and primary care physicians based on the existing body of clinical data. We discuss manifestations categorized into one of the following: eyelid, orbit, uveitis, retina, vascular, neuro-ophthalmology, ocular motility disorders, and other.